The Use of Ipratropium Bromide for the Management of Acute Asthma Exacerbation in Adults and Children: A Systematic Review

REFERENCES

• Beveridge R. C., Grunfeld A., Hodder R., Verbeek P. R. Guidelines for the Emergency Management of Asthma in Adults. Can. Med. Assoc. J. 1996; 155: 25–37
   PubMed Web of Science ®Google Scholar
• Richardson J. B. Nerve Supply to the Lungs. Am. Rev. Respir. Dis. 1979; 119: 785–802
   PubMed Web of Science ®Google Scholar
• Barnes P. J., Basbaum C. B., Nadel J. A. Autoradiographic Localization of Autonomic Receptors in Airway Smooth Muscle: Marked Differences Between Large and Small Airways. Am. Rev. Respir. Dis. 1983; 127: 758–762
   PubMed Web of Science ®Google Scholar
• Barnes P. J., Minette P., MacIagan J. Muscarinic Receptor Subtypes in the Airways. Trends Pharmacol. Sci. 1988; 9: 412–416
   PubMed Web of Science ®Google Scholar
• Doods H. N. Selective Muscarinic Antagonists as Bronchodilators. Drug News Perspect. 1992; 5: 345–352
   Google Scholar
• Barnes P. J. Muscarinic Receptors in the Airways: Recent Developments. J. Appl. Physiol. 1990; 68: 1777–1785
   PubMed Web of Science ®Google Scholar
• Jones C. A., Madison J. M., Tom-Moy M., Brown J. K. Muscarinic Cholinergic Inhibition of Adenylate Cyclase in Airway Smooth Muscle. Am. J. Physiol. 1987; 253: C90–C104
   Google Scholar
• Barnes P. J. Muscarinic Receptor Subtypes in Airways. Life Sci. 1993; 52: 521–527
   PubMed Web of Science ®Google Scholar
• Kalser S. C. The Fate of Atropine in Man. Ann. N.Y. Acad. Sci. 1971; 179: 667–683
   PubMed Web of Science ®Google Scholar
• Deckers W. The Chemistry of New Derivatives of Tropane Alkaloids and the Pharmacokinetics of a New Quaternary Compound. Postgrad. Med. J. 1975; 51(suppl 7)76–81
   PubMedGoogle Scholar
• Gross N. J., Skorodi M. S. Anticholinergic, Antimus-carinic Bronchodilators. Am. Rev. Respir. Dis. 1984; 129: 856–870
   PubMed Web of Science ®Google Scholar
• Francis R. A., Thomson M. L., Pavia D., Douglas R. B. Ipratropium Bromide: Mucociliary Clearance Rate and Airway Resistance in Normal Subjects. Br. J. Dis. Chest 1977; 71: 173–178
   PubMedGoogle Scholar
• Ruffin R. E., Wolff R. K., Dolovich M. B., Rossman C. M., Fitzgerald J. D., Newhouse MT. Aerosol Therapy with Sch 1000: Short-Term Mucociliary Clearance in Normal and Bronchitic Subjects and Toxicology in Normal Subjects. Chest 1978; 73: 501–506
   PubMedGoogle Scholar
• Pavia D., Bateman J. R.M., Sheahan N. F., Clarke S. W. Effect of Ipratropium Bromide on Mucociliary Clearance and Pulmonary Function in Reversible Airways Obstruction. Thorax 1979; 34: 501–507
   PubMedGoogle Scholar
• Bell J. A., Bluestein B. M., Danta I., Wanner A. Effect of Inhaled Ipratropium Bromide on Tracheal Mucociliary Transport in Bronchial Asthma. Mt. Sinai J. Med. (N.Y.) 1984; 51: 215–217
   PubMedGoogle Scholar
• Taylor R. G., Pavia D., Agnew J. E., Lopez-Vidriero M. T. et al. Effect of Four Weeks' High Dose Ipratropium Bromide Treatment on Lung Mucociliary Clearance. Thorax 1986; 4: 295–300
   Google Scholar
• Howarth P. H., Durham S. R., Lee T. H., Kay A. B., Church M. K., Holgate S. T. Influence of Albuterol, Cromolyn Sodium and Ipratropium Bromide on the Airways and Circulating Mediator Responses to Allergen Bronchial Provocation in Asthma. Am. Rev. Respir. Dis. 1985; 132: 986–992
   PubMed Web of Science ®Google Scholar
• Gross N. J. The Use of Anticholinergic Agents in the Treatment of Airways Disease. Clin. Chest. Med. 1988; 9: 591–598
   PubMed Web of Science ®Google Scholar
• Ruffin R. E., Fitzgerald J. D., Rebuck A. S. A Comparison of the Bronchodilator Activity of Sch 1000 and Salbutamol. J. Allergy Clin. Immunol. 1977; 59: 136–141
   PubMedGoogle Scholar
• Ziment I., Au J. P. Anticholinergic Agents. Clin. Chest Med. 1986; 7: 355–366
   PubMedGoogle Scholar
• Atrovent Inhalation Solution Product Monograph. Boehringer Ingelheim, Inc
   Google Scholar
• Scheufler G. Ophthalmotonometry, Pupil Diameter and Visual Accomodation Following Repeated Administration of Sch 1000 MDI in Patients with Glaucoma (Abstract). Postgrad. Med. J. 1975; 51(Suppl. 7)132
   Google Scholar
• Calverley P. M.A. Pharmacology of Bronchodilators Used in Obstructive Airways Disease. The Role of Anticholinergics in Chronic Obstructive Pulmonary Disease and Chronic Asthma, P. J. Barnes, A. S. Buist. Gardiner-Caldwell Communication Limited, CheshireUK 1997; 72–91
   Google Scholar
• Stoodley R. G., Aaron S. D., Dales R. E. The Role of Ipratropium Bromide in the Emergency Management of Acute Asthma Exacerbation: A Metaanalysis of Randomized Clinical Trials. Ann. Emerg. Med. 1999; 34: 8–18
   PubMed Web of Science ®Google Scholar
• DerSimonian R., Laird N. Meta-Analysis in Clinical Trials. Controlled Clinical Trials 1986; 7: 177–188
   PubMedGoogle Scholar
• Karpel J. P., Schacter E. N., Fanta C., Levey D., Spiro P., Aldrich T. et al. A Comparison of Ipratropium and Albuterol vs Albuterol Alone for the Treatment of Acute Asthma. Chest 1996; 110: 611–616
   PubMed Web of Science ®Google Scholar
• FitzGerald J. M., Grunfeld A., Pare P. D., Levy R. D., Newhouse M. T., Hodder R. et al. The Clinical Efficacy of Combination Nebulized Anticholinergic and Adrenergic Bronchodilators vs Nebulized Adrenergic Bronchodilator Alone in Acute Ashtma. Chest 1997; 111: 311–315
   PubMedGoogle Scholar
• Summers Q. A., Tarala R. A. Nebulized Ipratropium in the Treatment of Acute Asthma. Chest 1990; 97: 425–429
   PubMed Web of Science ®Google Scholar
• O'Driscoll B. R., Taylor R. J., Horsley M. G., Chambers D. K., Bernstein A. Nebulised Salbutamol with and Without Ipratropium Bromide in Acute Airflow Obstruction. Lancet 1989; 1: 1418–1420
   PubMed Web of Science ®Google Scholar
• Higgins R. M., Stradling J. R., Lane D. J. Should Ipratropium Bromide Be Added to Beta-Agonists in Treatment of Acute Severe Asthma. Chest 1988; 94: 718–722
   PubMed Web of Science ®Google Scholar
• Rebuck A. S., Chapman K. R., Abboud R., Pare P. D., Kreisman H., Wolkove N. et al. Nebulized Anticholinergic and Sympathomimetic Treatment of Asthma and Chronic Obstructive Airways Disease in the Emergency Room. Am. J. Med. 1987; 82: 59–64
   PubMed Web of Science ®Google Scholar
• Bryant D. H. Nebulized Ipratropium Bromide in the Treatment of Acute Asthma. Chest 1985; 88: 24–29
   PubMed Web of Science ®Google Scholar
• Ward M. J., Macfarlane J. T., Davies D. A Place for Ipratropium Bromide in the Treatment of Severe Acute Asthma. Br. J. Dis. Chest 1985; 79: 374–378
   PubMedGoogle Scholar
• Roeseler J., Reynaert M. S. A Comparison of Fenoterol and Fenoterol-Ipratropium Nebulisation Treatment in Acute Asthma. Acta Therapeutica 1987; 13: 571–578
   Google Scholar
• Garrett J. E., Town G. I., Rodwell P., Kelly A. Nebulized Salbutamol with and Without Ipratropium Bromide in the Treatment of Acute Asthma. J. Allergy Clin. Immunol. 1997; 100: 165–170
   PubMedGoogle Scholar
• Qureshi F., Pestian J., Davis P., Zaritsky A. Effect of Nebulized Ipratropium on the Hospitalization Rates of Children with Asthma. N. Engl. J. Med. 1998; 339: 1030–1035
   PubMed Web of Science ®Google Scholar
• Zorc J. J., Pusic M. V., Ogborn C. J., Lebet R., Duggan A. K. Ipratropium Bromide Added to Asthma Treatment in the Pediatric Emergency Department. Pediatrics 1999; 103: 748–752
   PubMed Web of Science ®Google Scholar
• Plotnick L. H., Ducharme F. M. The Cochrane Library 1999; 4: 1–14
   Google Scholar
• Martinez F., deOca M., Whyte R., Stetz J., Gay S., Celli B. Lung Volume Reduction Improves Dyspnea, Dynamic Hyperinflation, and Respiratory Muscle Function. Am. J. Respir. Crit. Care Med. 1997; 155: 1984–1990
   PubMed Web of Science ®Google Scholar
• Belman M., Botnick W., Shin J. Inhaled Bronchodilators Reduce Dynamic Hyperinflation During Exercise in Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 1996; 153: 967–975
   PubMed Web of Science ®Google Scholar